Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EPTIFIBATIDE Cause Haemoglobin decreased? 30 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Haemoglobin decreased have been filed in association with EPTIFIBATIDE (Eptifibatide). This represents 6.5% of all adverse event reports for EPTIFIBATIDE.

30
Reports of Haemoglobin decreased with EPTIFIBATIDE
6.5%
of all EPTIFIBATIDE reports
3
Deaths
15
Hospitalizations

How Dangerous Is Haemoglobin decreased From EPTIFIBATIDE?

Of the 30 reports, 3 (10.0%) resulted in death, 15 (50.0%) required hospitalization, and 7 (23.3%) were considered life-threatening.

Is Haemoglobin decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EPTIFIBATIDE. However, 30 reports have been filed with the FAERS database.

What Other Side Effects Does EPTIFIBATIDE Cause?

Product use in unapproved indication (61) Thrombocytopenia (58) Drug ineffective (39) Off label use (31) Haemorrhage (28) Vascular stent thrombosis (19) Condition aggravated (14) Gastrointestinal haemorrhage (14) Haematoma (14) Product use issue (14)

What Other Drugs Cause Haemoglobin decreased?

LENALIDOMIDE (4,031) RUXOLITINIB (3,297) ECULIZUMAB (3,028) ADALIMUMAB (2,459) CLOZAPINE (2,396) RITUXIMAB (1,803) APIXABAN (1,779) NIRAPARIB (1,759) METHOTREXATE (1,754) RIBAVIRIN (1,753)

Which EPTIFIBATIDE Alternatives Have Lower Haemoglobin decreased Risk?

EPTIFIBATIDE vs EPTINEZUMAB-JJMR EPTIFIBATIDE vs EPTINEZUMAB\EPTINEZUMAB-JJMR EPTIFIBATIDE vs EQUINE THYMOCYTE IMMUNE GLOBULIN EPTIFIBATIDE vs ERAVACYCLINE EPTIFIBATIDE vs ERBITUX

Related Pages

EPTIFIBATIDE Full Profile All Haemoglobin decreased Reports All Drugs Causing Haemoglobin decreased EPTIFIBATIDE Demographics